Personalized High-Dose Continuous Hyperfractionated Accelerated Radiotherapy (HI-CHART) of non-small cell lung cancer (NSCLC) based on normal tissue constraints: a prospective clinical trial: P3-046
暂无分享,去创建一个
P. Lambin | L. Boersma | D. de Ruysscher | G. Bootsma | W. Geraedts | C. Pitz | J. Simons | A. V. van Baardwijk | A. Dingemans | R. Wanders